US Patent 7514076 Antitumor agents
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+395 characters)
Article
Patent abstract
An antitumor agent, which is a combination of an oxidoreductase, such as xanthine oxidase chemically conjugated to a polymer such as poly ethylene glycol, for initial administration and accumulation in the tumor tissue followed by administration and of a substrate for the oxidoreductase which releases reactive oxygen species. Improved tumor selective cytotoxic activity results.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07514076 Antitumor agents US Patent 7514076 Antitumor agents
Infobox
Patent Number
0751407600
Patent Number
751407600
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075140760
Date of Patent
April 7, 2009
0Patent Application Number
114859700
Date Filed
July 14, 2006
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075140760
Date of Patent
April 7, 2009
0Patent Application Number
114859700
Date Filed
July 14, 2006
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07514076 Antitumor agents
Infobox
Is a
Patent jurisdiction
Patent number
07514076
Date of patent
April 7, 2009
Patent application number
11485970
Date Filed
July 14, 2006
Patent primary examiner
Find more entities like US Patent 7514076 Antitumor agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
